IT8720229A0 - Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina - Google Patents

Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina

Info

Publication number
IT8720229A0
IT8720229A0 IT8720229A IT2022987A IT8720229A0 IT 8720229 A0 IT8720229 A0 IT 8720229A0 IT 8720229 A IT8720229 A IT 8720229A IT 2022987 A IT2022987 A IT 2022987A IT 8720229 A0 IT8720229 A0 IT 8720229A0
Authority
IT
Italy
Prior art keywords
idanpramine
adaptivity
spasmolytic
pharmaceutical compositions
active principle
Prior art date
Application number
IT8720229A
Other languages
English (en)
Other versions
IT1215441B (it
Inventor
Lucia Mazzoni
Original Assignee
Ibis Ist Biochim Speriment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibis Ist Biochim Speriment filed Critical Ibis Ist Biochim Speriment
Priority to IT8720229A priority Critical patent/IT1215441B/it
Publication of IT8720229A0 publication Critical patent/IT8720229A0/it
Priority to JP63503658A priority patent/JPH03500163A/ja
Priority to EP88903795A priority patent/EP0358665A1/en
Priority to KR1019880701708A priority patent/KR890700580A/ko
Priority to AU16850/88A priority patent/AU1685088A/en
Priority to PCT/EP1988/000318 priority patent/WO1988008421A1/en
Application granted granted Critical
Publication of IT1215441B publication Critical patent/IT1215441B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8720229A 1987-04-23 1987-04-23 Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina IT1215441B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8720229A IT1215441B (it) 1987-04-23 1987-04-23 Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina
JP63503658A JPH03500163A (ja) 1987-04-23 1988-04-15 鎮痙活性を有する製薬組成物
EP88903795A EP0358665A1 (en) 1987-04-23 1988-04-15 Pharmaceutical compositions having spasmolytic activity
KR1019880701708A KR890700580A (ko) 1987-04-23 1988-04-15 진경 작용을 갖는 제약 조성물
AU16850/88A AU1685088A (en) 1987-04-23 1988-04-15 Pharmaceutical compositions having spasmolytic activity
PCT/EP1988/000318 WO1988008421A1 (en) 1987-04-23 1988-04-15 Pharmaceutical compositions having spasmolytic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8720229A IT1215441B (it) 1987-04-23 1987-04-23 Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina

Publications (2)

Publication Number Publication Date
IT8720229A0 true IT8720229A0 (it) 1987-04-23
IT1215441B IT1215441B (it) 1990-02-14

Family

ID=11164959

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8720229A IT1215441B (it) 1987-04-23 1987-04-23 Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina

Country Status (6)

Country Link
EP (1) EP0358665A1 (it)
JP (1) JPH03500163A (it)
KR (1) KR890700580A (it)
AU (1) AU1685088A (it)
IT (1) IT1215441B (it)
WO (1) WO1988008421A1 (it)

Also Published As

Publication number Publication date
IT1215441B (it) 1990-02-14
KR890700580A (ko) 1989-04-25
AU1685088A (en) 1988-12-02
EP0358665A1 (en) 1990-03-21
WO1988008421A1 (en) 1988-11-03
JPH03500163A (ja) 1991-01-17

Similar Documents

Publication Publication Date Title
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK435688D0 (da) Farmaceutiske midler
IT8521498A0 (it) Isoindolinil-alchil-piperazine adattivita' farmaceutica.
IT8319958A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
IT8619162A0 (it) Composti acilamminoalcanoilici adattivita' farmaceutica.
MX11584A (es) Composiciones farmaceuticas
IT8720229A0 (it) Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina
IT8322427A0 (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
IT8520273A0 (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
IT8847610A0 (it) Composizioni farmaceutiche adattivita' antiprolattinica
IT8220251A0 (it) Composizione farmaceutica adattivita' immunomodulatrice.
IT8621925A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8720701A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
IT8719949A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
FR2608597B1 (fr) Compositions pharmaceutiques contenant de l'acetylsalicylate de lysine
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
IT8322815A0 (it) Formulazioni farmaceutiche adattivita' antisettica.
IT8323632A0 (it) Composizioni farmaceutiche adattivita'antibatterica-immunostimolante.
IT8820026A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8222225A0 (it) Composizione farmaceutica adattivita' antiulcera.